Novel chikungunya and dengue vaccines: travel medicine applications

J Travel Med. 2024 Jun 3;31(4):taae064. doi: 10.1093/jtm/taae064.

Robert Steffen^{1

2}, Davidson H Hamer³, Lin H Chen^{4

5}, Eric Caumes⁶, Colleen L Lau⁷

¹ Epidemiology, Biostatistics and Prevention Institute, Department of Public and Global Health, Division of Infectious Diseases, World Health Organization Collaborating Centre for Travelers' Health, University of Zurich, Zurich, Switzerland.
² Division of Epidemiology, Human Genetics & Environmental Sciences, University of Texas School of Public Health, Houston, TX, USA.
³ Department of Global Health, Boston University School of Public Health; Section of Infectious Diseases, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine; and Center on Emerging Infectious Disease, Boston University, Boston, MA, USA.
⁴ Division of Infectious Diseases and Travel Medicine, Mount Auburn Hospital, Cambridge, MA, USA.
⁵ Faculty of Medicine, Harvard Medical School, Boston, MA, USA.
⁶ Infectious and Tropical Diseases. Hopital de l'Hotel-Dieu & Sorbonne University, Paris, France.
⁷ UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, Australia.

No abstract available

Keywords: Ixchiq; Qdenga; antibody dependent enhancement; arbovirus; mosquito-borne; prevention.

MeSH terms